DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 207066
NDA 207066 describes NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, which is a drug marketed by Accord Hlthcare, Amneal Pharms, Apil, Barr, Lupin Ltd, and Mylan Labs Ltd, and is included in seven NDAs. It is available from five suppliers. There is one patent protecting this drug. Additional details are available on the NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE profile page.
The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 207066
| Tradename: | NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE |
| Applicant: | Accord Hlthcare |
| Ingredient: | ethinyl estradiol; norethindrone |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 0.035MG;0.4MG | ||||
| Approval Date: | Mar 29, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
